Drawing for PALISADE BIO

USPTO serial 90086854

PALISADE BIO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RITTNER, HANNO I
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PALISADE BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Y. Jae Kim

Y. Jae Kim Kim IP Law Group LLC129 W. Evesham RoadVoorhees, NJ 08043UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and postsurgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock, hemorrhagic shock, and shock associated with hypoperfusion; Pharmaceutical formulations and preparations to treat or prevent gastrointestinal tract injuries, ileus, and adhesions; Pharmaceutical formulations and preparations to treat or prevent multiorgan failure; Pharmaceutical formulations and preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 18, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 18, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 25, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2023EX4GSOU EXTENSION 4 GRANTED—
May 24, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 6, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Apr 5, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 5, 2023PETGPETITION TO REVIVE-GRANTED—
Apr 5, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Apr 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 4, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 20, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 20, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 16, 2023EXT4SOU EXTENSION 4 FILED—
Aug 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 15, 2022EX3GSOU EXTENSION 3 GRANTED—
Aug 15, 2022EXT3SOU EXTENSION 3 FILED—
Aug 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 8, 2022EX2GSOU EXTENSION 2 GRANTED—
Feb 8, 2022EXT2SOU EXTENSION 2 FILED—
Feb 8, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 17, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 14, 2021EX1GSOU EXTENSION 1 GRANTED—
Aug 14, 2021EXT1SOU EXTENSION 1 FILED—
Aug 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 16, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 22, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 22, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 2, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Nov 19, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 19, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 19, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 19, 2020DOCKASSIGNED TO EXAMINER—
Sep 1, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance